Latest News

San Francisco, California (UroToday.com) Dr. Paul Russo reviewed that after open resection of localized renal cell carcinoma (RCC), 11% of patients will recur with 1% having local recurrence at 60 months. Over the last 15-years they have managed patients treated with minimally-invasive-surgery (MIS) who developed unusual patterns of recurrence. Recently, the FDA released a cautionary […]

San Francisco, California (UroToday.com) Gordon Hong noted radical nephrectomy with removal of tumor thrombus is considered standard of care in patients with non-metastatic renal cell carcinoma (RCC). Surgical resection usually consists of nephrectomy and thrombectomy; however, ligation of the IVC is sometimes necessary. This study assessed the outcomes, particularly functional outcomes, in RCC patients undergoing […]

San Francisco, California (UroToday.com) Dr. Preston Kerr discussed how exposure to aromatic amines is a risk factor for bladder cancer. Incidence rates according to proximity to oil refineries are largely unknown. They sought to determine the proximity of oil refineries and bladder cancer incidence in the State of Texas which is home to the largest […]

San Francisco, California (UroToday.com) Julianne R. Rathbun, MD, general surgeon, University of Missouri, Columbia, Missouri highlighted radical cystectomy (RC) with urinary diversion for muscle-invasive urothelial cell carcinoma of the bladder is an aggressive intervention with high morbidity secondary to high readmission rates and complications. She performed a study which aimed to determine readmission rates after […]

San Francisco, California (UroToday.com) Mark Ehlers, MD, University of North Carolina, Chapel Hill, NC, reviewed how bladder cancer is the most expensive cancer from diagnosis to death. Financial toxicity (FT) is distress related to the cost of medical care. Worse FT has been reported in younger, Black, less educated, and non-muscle-invasive disease bladder cancer patients. In […]

San Francisco, California (UroToday.com) William M. Worrilow, BA, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, Carolinas Medical Center, Atrium Health, Charlotte, North Carolina, presented results from a single institution early recovery after surgery (ERAS) audit. They utilized the ERAS Society’s compliance guidelines to direct perioperative care of RCUD patients. They aimed to study the […]

The use of adjuvant radiotherapy (RT) after radical prostatectomy (RP) is very limited in prostate cancer patients mainly due to concerns for worsening of functional outcomes with early delivery of RT. We sought to test the impact of timing between RP and RT on adverse events rate. Using the Radiation Therapy Oncology Group (RTOG) 9601 […]

Prostate cancer (PCa) treatment has a significant negative impact on sexual function. Because research to this date has mostly focused on the impact of PCa on erectile function, very little is known about the impact of PCa on other relevant sexual outcomes, such as sexual satisfaction. To conduct a literature review of studies that have […]

To evaluate whether African American (AA) men are at higher risk of reclassification in a large, prospective multi-institutional active surveillance (AS) cohort. The Canary Prostate Active Surveillance Study (PASS) is a protocol-driven active surveillance cohort with pre-specified prostate-specific antigen (PSA) and surveillance biopsies regimen. Men included in this study had Gleason Grade Group 1 or […]

Although the clinical use of multiparametric prostate magnetic resonance imaging (mpMRI) is increasing, the adherence to parameters for mpMRI which had been described in the Prostate Imaging-Reporting and Data System version 2 (PI-RADSv2) for an optimum image acquisition is unknown. In this paper, we aimed to determine the compliance with the minimum acceptable technical parameters […]